Plant-based ALiCE® technology could shave weeks off vaccine production
LenioBio GmbH has received CEPI funding of up to US $2 million to provide preclinical proof-of-concept that their commercially available, plant-based, and cell-free technology can produce proteins for use in clinical trials testing vaccines against epidemic and pandemic threats in 20-40 days.
List of Services
-
LenioBio Appoints CTO and CCO to Spearhead Growth and Innovation
LenioBio today announced the appointments of Kathrin Knauf as Chief Technology Officer and Malene Linderoth as Chief Commercial Officer.
-
LenioBio appoints Hugh Watson as CFO
LenioBio appoints High Waston as Chief Financial Officer as of January 1st, 2024. Hugh brings with him a wealth of experiene and strategic financial insight.
-
LenioBio announces new CEOList Item 2
LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, starting June 1st, 2023.
-
A new member to LenioBio's Scientific Advisory BoardList Item 1
Prof. Bracewell is appointed member of LenioBio's Scientific Advisory Board.
-
A new member for LenioBio's leadership teamList Item 3
Jasper Levink joined LenioBio in January 2022 as Lead of the Business Unit...
-
LenioBio reaches industrial-scale with protein expression platform ALiCE®
LenioBio reaches industrial-scale with its high-yield eukaryotic platform for cell-free protein synthesis.
-
A breakthrough in biopharmaceutical protein productionList Item 4
LenioBio generated a novel plant glycan knockout cell line that will increase the versatility and flexibility...
-
LenioBio awarded prestigious Eurostars grant
LenioBio GmbH announced today that the company has been awarded a grant...
-
LenioBio closes its Series-A Extension round, strengthening board of directors.
LenioBio closed its Series-A Extension round with a total investment volume of €11.5 million and strengtheneds its board of directors.
-
LenioBio announces new appointment to the Scientific Advisory Board
New Scientific Advisory Board composed of experts within the field of biotechnology and manufacturing of biopharmaceuticals.
-
LenioBio accesses tailor-made business opportunities with AB InBev
Companies supported under the European Innovation Council had the opportunity to accelerate their business...
-
LenioBio Announces Scientific Advisory Board
New Scientific Advisory Board composed of experts within the field of Biotechnology.
-
LenioBio Won Prestigious Horizon 2020 SME/2 Grant
The company has been awarded a grant to accelerate the scale-up of its proprietary protein expression platform ALiCE.
Older releases
